Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):639-45. doi: 10.1161/01.ATV.0000154359.60886.33. Epub 2004 Dec 23.

Abstract

Objective: Oxidized low-density lipoprotein (oxLDL)-induced apoptosis of vascular endothelial cells may contribute to plaque erosion and rupture. We aimed to clarify the relationship between the oxLDL-induced calcium signal and induction of apoptotic pathways.

Methods and results: Apoptosis was evaluated by biochemical methods, including studies of enzyme activities, protein processing, release of proapoptotic factors, chromatin cleavage, and especially by morphological methods that evaluate apoptosis/necrosis by SYTO-13/propidium iodide fluorescent labeling. The oxLDL-induced sustained calcium rise activated 2 distinct calcium-dependent mitochondrial apoptotic pathways in human microvascular endothelial cells. OxLDLs induced calpain activation and subsequent Bid cleavage and cytochrome C release, which were blocked by calpeptin. Cyclosporin-A inhibited cytochrome C release, possibly by inhibiting the opening of the mitochondrial permeability transition pore (mPTP). Calcineurin, another cyclosporin-sensitive step, was not implicated, because oxLDLs inhibited calcineurin and FK-506 treatment was ineffective. Cytochrome C release in turn induced caspase-3 activation. In addition, oxLDLs triggered release and nuclear translocation of mitochondrial apoptosis-inducing factor through a mechanism dependent on calcium but independent of calpains, mPTP, and caspases.

Conclusions: OxLDL-induced apoptosis involves 2 distinct calcium-dependent pathways, the first mediated by calpain/mPTP/cytochrome C/caspase-3 and the second mediated by apoptosis-inducing factor, which is cyclosporin-insensitive and caspase-independent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Apoptosis Inducing Factor
  • Arteriosclerosis / metabolism*
  • Arteriosclerosis / pathology
  • BH3 Interacting Domain Death Agonist Protein
  • Calcium / metabolism*
  • Calpain / metabolism
  • Carrier Proteins / metabolism
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / metabolism
  • Cells, Cultured
  • Cyclosporine / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochromes c / metabolism
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / metabolism*
  • Flavoproteins / metabolism
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Lipoproteins, LDL / metabolism*
  • Membrane Proteins / metabolism
  • Microcirculation
  • Mitochondria / metabolism*
  • Tacrolimus / pharmacology

Substances

  • AIFM1 protein, human
  • Apoptosis Inducing Factor
  • BH3 Interacting Domain Death Agonist Protein
  • BID protein, human
  • Carrier Proteins
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Flavoproteins
  • Immunosuppressive Agents
  • Lipoproteins, LDL
  • Membrane Proteins
  • oxidized low density lipoprotein
  • Cyclosporine
  • Cytochromes c
  • CASP3 protein, human
  • Calpain
  • Caspase 3
  • Caspases
  • Calcium
  • Tacrolimus